Latest Insider Transactions at Milestone Pharmaceuticals Inc. (MIST)
This section provides a real-time view of insider transactions for Milestone Pharmaceuticals Inc. (MIST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Milestone Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Milestone Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2023
|
Rtw Investments, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,059,000
-24.54%
|
-
|
|
Dec 05
2022
|
David Bharucha Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+41.18%
|
$28,000
$4.69 P/Share
|
|
Dec 01
2022
|
David Bharucha Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$12,000
$4.86 P/Share
|
|
Oct 21
2022
|
Debra K. Liebert Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+50.0%
|
$20,000
$5.26 P/Share
|
|
Oct 20
2022
|
Richard C Pasternak Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$50,000
$5.2 P/Share
|
|
Oct 20
2022
|
Debra K. Liebert Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$50,000
$5.29 P/Share
|
|
Oct 19
2022
|
Robert James Wills |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$60,000
$4.93 P/Share
|
|
Oct 19
2022
|
Michael John Tomsicek |
BUY
Open market or private purchase
|
Direct |
15,000
+50.0%
|
$75,000
$5.32 P/Share
|
|
Sep 14
2022
|
Debra K. Liebert Director |
BUY
Other acquisition or disposition
|
Direct |
127
+50.0%
|
-
|
|
Sep 07
2022
|
Rtw Investments, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,557,346
-26.52%
|
$12,458,768
$8.71 P/Share
|
|
Sep 07
2022
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,557,346
+26.52%
|
$12,458,768
$8.71 P/Share
|
|
May 31
2022
|
Paul F Truex Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.76%
|
$25,000
$5.6 P/Share
|
|
May 31
2022
|
Paul F Truex Director |
BUY
Exercise of conversion of derivative security
|
Direct |
76,780
+30.03%
|
$76,780
$1.72 P/Share
|
|
Mar 19
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,870
+0.14%
|
$58,700
$10.87 P/Share
|
|
Mar 18
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,705
+0.06%
|
$27,050
$10.36 P/Share
|
|
Mar 02
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
78,263
+1.78%
|
$1,408,734
$18.95 P/Share
|
|
Jan 13
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
270,000
+6.0%
|
$4,320,000
$16.25 P/Share
|
|
Dec 31
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,438
+0.54%
|
$321,570
$15.5 P/Share
|
|
Dec 30
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,333
+0.03%
|
$19,995
$15.48 P/Share
|
|
Nov 25
2019
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
240,000
-8.97%
|
$3,840,000
$16.0 P/Share
|
|
Nov 20
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+9.23%
|
$6,400,000
$16.0 P/Share
|
|
Oct 15
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,100
+0.03%
|
$19,800
$18.0 P/Share
|
|
Oct 11
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,208
+0.12%
|
$71,536
$17.3 P/Share
|
|
Oct 10
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
179
+0.01%
|
$2,864
$16.0 P/Share
|
|
Oct 03
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,908
+0.05%
|
$34,344
$18.31 P/Share
|
|
Oct 01
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,242
+0.18%
|
$106,114
$17.63 P/Share
|
|
May 13
2019
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
333,333
+11.08%
|
$4,999,995
$15.0 P/Share
|
|
May 13
2019
|
Novo Holdings > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
2,341,137
+39.58%
|
-
|
|
May 09
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
666,667
+15.92%
|
$10,000,005
$15.0 P/Share
|
|
May 09
2019
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,855,189
+28.33%
|
-
|